Advertisement

Utility of the HAS-BLED score for risk stratification of patients with acute coronary syndrome

  • Diego CastiniEmail author
  • Simone Persampieri
  • Ludovico Sabatelli
  • Massimo Erba
  • Giulia Ferrante
  • Federica Valli
  • Marco Centola
  • Stefano Carugo
Original Article

Abstract

HAS-BLED score was developed for bleeding prediction in patients with atrial fibrillation (AF). Recently, it was also used in patients undergoing percutaneous coronary interventions (PCI). This study analyzes the HAS-BLED predictivity for bleedings and mortality in patients with acute coronary syndromes (ACS) without AF, and evaluates the utilization of alternative criteria for renal dysfunction. The study population was composed of 704 patients with ACS. Six-hundred and eleven patients completed the follow-up. The HAS-BLED score was calculated both using the original definition of renal dysfunction, both using three alternative eGFR thresholds (< 30, < 60 and ≤ 90 ml/min/1.73 mq). In-hospital and post-discharge bleedings and mortality were recorded, and calibration and discrimination of the various risk models were evaluated using the Hosmer–Lemeshow test and the C-statistic. In-hospital bleedings were 4.7% and mortality was 2.7%. Post-discharge bleedings were 3.1% and mortality was 4.4%. Regarding bleeding events and in-hospital mortality, the HAS-BLED original risk model demonstrated a moderate-to-good discriminative performance (C-statistics from 0.65 to 0.76). No significant differences were found in predictive accuracy when applying alternative definitions of renal dysfunction based on eGFR, with the exception of post-discharge mortality, for which HAS-BLED model assuming an eGFR value < 60 ml/min/1.73 mq showed a discriminative performance significantly higher in comparison to the other risk models (C-statistic 0.71 versus 0.64–0.66). In conclusion, in our ACS population, the HAS-BLED risk score showed a fairly good predictive accuracy regarding in-hospital and follow-up bleeding events and in-hospital mortality. The use of renal dysfunction alternative criteria based on eGFR values resulted in out-of hospital mortality predictive accuracy enhancement.

Keywords

Acute coronary syndrome Atrial fibrillation Bleeding eGFR HAS-BLED Risk scores 

Notes

Acknowledgements

The authors acknowledge the “Centro di Ricerca Aldo Ravelli” for supporting the study. We specify that they did not have any role in the design or conduct of the study, the collection, management, analysis, or interpretation of the data, the preparation of the manuscript, or the decision to publish.

Funding

This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

Compliance with ethical standards

Conflict of interests

The authors state that they have no conflict of interest.

References

  1. 1.
    Eikelboom JW, Metha SR, Anand SS, Xie C, Fox KA, Yusuf S (2006) Adverse impact of bleeding on prognosis in patients with acute coronary syndromes. Circulation 114:774–782CrossRefGoogle Scholar
  2. 2.
    Kadakia MB, Desai NR, Alexander KP, Chen AY, Foody JM, Cannon CP, Wiviott SD, Scirica BM (2010) Use of anticoagulant agents and risk of bleeding among patients admitted with myocardial infarction: a report from the NCDR ACTION Registry_GWTG. JACC Cardiovasc Interv 3:1166–1177CrossRefGoogle Scholar
  3. 3.
    Fox KA, Carruthers K, Steg PG, Avezum A, Granger CB, Montalescot G, Goodman SG, Gore JM, Quill AL, Eagle KA (2010) Has the frequency of bleeding changed over time for patients presenting with an acute coronary syndrome? The global registry of acute coronary events. Eur Heart J 31:667–675CrossRefGoogle Scholar
  4. 4.
    Bonaca MP, Bhatt DL, Cohen M, Steg PG, Storey RF, Jensen EC, Magnani G, Bansilal S, Fish MP, Im K, Bengtsson O, Oude Ophuis T, Budaj A, Theroux P, Ruda M, Hamm C, Goto S, Spinar J, Nicolau JC, Kiss RG, Murphy SA, Wiviott SD, Held P, Braunwald E, Sabatine MS (2015) Long-term use of ticagrelor in patients with prior myocardial infarction. N Engl J Med 372:1791–1800CrossRefGoogle Scholar
  5. 5.
    Valgimigli M, Costa F, Byrne R, Haude M, Baumbach A, Windecker S (2015) Dual antiplatelet therapy duration after coronary stenting in clinical practice: results of an EAPCI survey. EuroIntervention 11:68–74CrossRefGoogle Scholar
  6. 6.
    Rao SV, O’Grady K, Pieper KS, Granger CB, Newby LK, Van de Werf F, Mahaffey KW, Califf RM, Harrington RA (2005) Impact of bleeding severity on clinical outcomes among patients with acute coronary syndromes. Am J Cardiol 96:1200–1206CrossRefGoogle Scholar
  7. 7.
    Manoukian SV, Feit F, Mehran R, Voeltz MD, Ebrahimi R, Hamon M, Dangas GD, Lincoff AM, White HD, Moses JW, King SB 3rd, Ohman EM, Stone GW (2007) Impact of major bleeding on 30-days mortality and clinical outcomes in patients with acute coronary syndromes: an analysis from the ACUITY trial. J Am Coll Cardiol 49:1362–1368CrossRefGoogle Scholar
  8. 8.
    Ndrepepa G, Berger PB, Mehilli J, Seyfarth M, Neumann FJ, Schömig A, Kastrati A (2008) Periprocedural bleeding and 1-year outcome after percutaneous interventions: appropriateness of including bleeding as a component of a quadruple end-point. J Am Coll Cardiol 51:690–697CrossRefGoogle Scholar
  9. 9.
    Suh JW, Mehran R, Claessen BE, Xu K, Baber U, Dangas G, Parise H, Lansky AJ, Witzenbichler B, Grines CL, Guagliumi G, Kornowski R, Wöhrle J, Dudek D, Weisz G, Stone GW (2011) Impact of in-hospital major bleeding on late clinical outcomes after primary percutaneous intervention in acute myocardial infarction. The HORIZONS-AMI (Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction) Trial. J Am Coll Cardiol 58:1750–1756CrossRefGoogle Scholar
  10. 10.
    Vranckx P, White HD, Huang Z, Mahaffey KW, Armstrong PW, Van de Werf F, Moliterno DJ, Wallentin L, Held C, Aylward PE, Cornel JH, Bode C, Huber K, Nicolau JC, Ruzyllo W, Harrington RA, Tricoci P (2016) Validation of BARC bleeding criteria in patients with acute coronary syndromes. The TRACER Trial. J Am Coll Cardiol 67:2135–2144CrossRefGoogle Scholar
  11. 11.
    Valgimigli M, Costa F, Lokhnygina Y, Clare RM, Wallentin L, Moliterno DJ, Armstrong PW, White HD, Held C, Aylward PE, Van de Werf F, Harrington RA, Mahaffey KW, Tricoci P (2017) Trade-off of myocardial infarction vs. bleeding types on mortality after acute coronary syndrome: lessons from the Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER) randomized trial. Eur Heart J 38:804–810Google Scholar
  12. 12.
    Steg PG, Huber K, Andreotti F, Arnesen H, Atar D, Badimon L, Bassand JP, De Caterina R, Eikelboom JA, Gulba D, Hamon M, Helft G, Fox KAA, Kristensen SD, Rao SV, Verheugt FWA, Widimsky P, Zeymer U, Collet JP (2011) Bleeding in acute coronary syndromes and percutaneous coronary interventions: position paper by the Working Group on Thrombosis of the European Society of Cardiology. Eur Heart J 32:1854–1864CrossRefGoogle Scholar
  13. 13.
    Subherwal S, Bach RG, Chen AY, Gage BF, Rao SV, Newby LK, Wang TY, Gibler WB, Ohman EM, Roe MT, Pollack CV Jr, Peterson ED, Alexander KP (2009) Baseline risk of major bleeding in non-ST-segment-elevation myocardial infarction: the CRUSADE (Can Rapid risk stratification of Unstable angina patients Suppress Adverse outcome with Early implementation of the ACC/AHA Guidelines) bleeding score. Circulation 119:1873–1882CrossRefGoogle Scholar
  14. 14.
    Mehran R, Pocock SJ, Nikolsky E, Clayton T, Dangas GD, Kirtane AJ, Parise H, Fahy M, Manoukian SV, Feit F, Ohman ME, Witzenbichler B, Guagliumi G, Lansky AJ, Stone GW (2010) A risk score to predict bleeding in patients with acute coronary syndromes. J Am Coll Cardiol 55:2556–2566CrossRefGoogle Scholar
  15. 15.
    Palmerini T, Genereux P, Caixeta A, Cristea E, Lansky A, Mehran R, Della Riva D, Fahy M, Xu K, Stone GW (2012) A new score for risk stratification of patients with acute coronary syndromes undergoing percutaneous coronary intervention: the ACUITY-PCI (Acute Catheterization and Urgent Intervention Triage strategY-Percutaneous Coronary Intervention) risk score. JACC Cardiovasc Interv 5:1108–1116CrossRefGoogle Scholar
  16. 16.
    Mathews R, Peterson ED, Chen AY, Wang TY, Chin CT, Fonarow GC, Cannon CP, Rumsfeld JS, Roe MT, Alexander KP (2011) In-hospital major bleeding during ST-elevation and non-ST-elevation myocardial infarction care: derivation and validation of a model from the ACTION Registry(R)-GWTG. Am J Cardiol 107:1136–1143CrossRefGoogle Scholar
  17. 17.
    Baber U, Mehran R, Giustino G, Cohen DJ, Henry TD, Sartori S, Ariti C, Litherland C, Dangas G, Gibson CM, Krucoff MW, Moliterno DJ, Kirtane AJ, Stone GW, Colombo A, Chieffo A, Kini AS, Witzembichler B, Weisz G, Steg PG, Pocock S (2016) Coronary thrombosis and major bleeding after PCI with drug-eluting stents: risk score from PARIS. J Am Coll Cardiol 67:2224–2234CrossRefGoogle Scholar
  18. 18.
    Costa F, van Klaveren D, James S, Heg D, Raber L, Feres F, Pilgrim T, Hong MK, Kim HS, Colombo A, Steg PG, Zanchin T, Palmerini T, Wallentin L, Bhatt DL, Stone GW, Windecker S, Steyerberg EW, Valgimigli M (2017) Derivation and validation of the predicting bleeding complications in patients undergoing stent implantation and subsequent dual antiplatelet therapy (PRECISE-DAPT) score: a pooled analysis of individual-patient datasets from clinical trials. Lancet 389:1025–1034CrossRefGoogle Scholar
  19. 19.
    Ko SQ, Valsdottir LR, Strom JB, Cheng YC, Hirayama A, Liu PH, Yanagisawa N, Yen H, Shen C, Yeh RW (2018) Meta-analysis of bleeding risk prediction scores in patients after percutaneous coronary intervention on dual platelet therapy. Am J Cardiol 122:1843–1852CrossRefGoogle Scholar
  20. 20.
    Pisters R, Lane DA, Nieuwlaat R, de Vos CB, Crijns HJGM, Lip GYH (2010) A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation. The Euro Heart Survey. Chest 138:1093–1100CrossRefGoogle Scholar
  21. 21.
    Gallego P, Roldan V, Torregrossa JM, Galvez J, Valdes M, Vicente V, Marin F, Lip GY (2012) Relation of the HAS-BLED bleeding risk score to major bleeding, cardiovascular events, and mortality in anticoagulated patients with atrial fibrillation. Circ Arrhythm Electrophysiol 5:312–318CrossRefGoogle Scholar
  22. 22.
    Kiviniemi T, Puurunen M, Schlitt A, Rubboli A, Karjalainen P, Vikman S, Niemela M, Lathela H, Lip GY, Airaksinen KE (2014) Performance of bleeding risk-prediction scores in patients with atrial fibrillation undergoing percutaneous coronary intervention. Am J Cardiol 113:1995–2001CrossRefGoogle Scholar
  23. 23.
    Puurunen MK, Kiviniemi T, Schlitt A, Rubboli A, Dietrich B, Karjalainen P, Nyman K, Niemela M, Lip GY, Airaksinen KE (2014) CHADS2, CHA2DS2-Vasc and HAS-BLED as predictors of outcome in patients with atrial fibrillation undergoing percutaneous coronary intervention. Thromb Res 133:560–566CrossRefGoogle Scholar
  24. 24.
    Konishi H, Miyauchi K, Tsuboi S, Ogita M, Naito R, Dohi T, Kasai T, Tamura H, Okazaki S, Isoda K, Daida H (2015) Impact of the HAS-BLED score on long-term outcomes after percutaneous coronary intervention. Am J Cardiol 116:527–531CrossRefGoogle Scholar
  25. 25.
    Costa F, Tijssen JG, Ariotti S, Giatti S, Moscarella E, Guastaroba P, De Palma R, Andò G, Oreto G, Zijlstra F, Valgimigli M (2015) Incremental value of the CRUSADE, ACUITY, and HAS-BLED risk scores for the prediction of hemorrhagic events after coronary stent implantation in patients undergoing long or short duration of dual antiplatelet therapy. J Am Heart Assoc 4:e002524CrossRefGoogle Scholar
  26. 26.
    Capodanno D, Rossini R, Musumeci G, Lettieri C, Senni M, Valsecchi O, Angiolillo DJ, Lip GYH (2015) Predictive accuracy of CHA2DS2-VASc and HAS-BLED scores in patients without atrial fibrillation undergoing percutaneous coronary intervention and discharged on dual antiplatelet therapy. Int J Cardiol 199:319–325CrossRefGoogle Scholar
  27. 27.
    Shah RR, Pillai A, Omar A, Zhao J, Arora V, Kapoor D, Poommipanit P (2017) Utility of HAS-BLED score in risk stratifying patients on dual antiplatelet therapy post 12 months after drug-eluting stent placement. Cath Cardiovasc Interv 89:E99–E103CrossRefGoogle Scholar
  28. 28.
    Smith JG, Wieloch M, Koul S, Braun OO, Lumsden J, Rydell E, Ohman J, Schersten F, Svensson PJ, van der Pals J (2012) Triple antithrombotic therapy following an acute coronary syndrome: prevalence, outcomes and prognostic utility of the HAS-BLED score. EuroIntervention 8:672–678CrossRefGoogle Scholar
  29. 29.
    Hsieh MJ, Wang CC, Chen CC, Wang CL, Wu LS, Hsieh IC (2015) HAS-BLED score predicts risk of in-hospital major bleeding in patients with acute non-ST segment elevation myocardial infarction. Thromb Res 136:775–780CrossRefGoogle Scholar
  30. 30.
    Hsieh MJ, Lee CH, Chen CC, Chang SH, Wang CY, Hsieh IC (2017) Predictive performance of HAS-BLED risk score for long-term survival in patients with non-ST elevated myocardial infarction without atrial fibrillation. J Cardiol 69:136–143CrossRefGoogle Scholar
  31. 31.
    Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J, CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration) (2009) A new equation to estimate glomerular filtration rate. Ann Intern Med 150:604–612CrossRefGoogle Scholar
  32. 32.
    Mehran R, Rao SV, Bhatt DL, Gibson CM, Caixeta A, Eikelboom J, Kaul S, Wiviott SD, Menon V, Nikolsky E, Serebruany V, Valgimigli M, Vranckx P, Taggart D, Sabik JF, Cutlip DE, Krucoff MW, Ohman EM, Steg PG, White H (2011) Standardized bleeding definitions for cardiovascular clinical trials: a consensus from the Bleeding Academic Research Consortium. Circulation 123:2736–2747CrossRefGoogle Scholar
  33. 33.
    Lemeshow S, Hosmer D (1982) A review of goodness of fit statistic for use in the development of logistic regression models. Am J Epidemiol 115:92–106CrossRefGoogle Scholar
  34. 34.
    DeLong ER, DeLong DM, Clarke-Pearson DL (1988) Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 44:837–845CrossRefGoogle Scholar
  35. 35.
    Mak KH, Bhatt DL, Shao M, Hankey GJ, Easton JD, Fox KA, Topol EJ (2009) Ethnic variation in adverse cardiovascular outcomes and bleeding complications in the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) study. Am Heart J 157:658–665CrossRefGoogle Scholar
  36. 36.
    Saunders E, Ofili E (2008) Epidemiology of atherothrombotic disease and the effectiveness and riskd of antiplatelet therapy: race and ethnic considerations. Cardiol Rev 16:82–88CrossRefGoogle Scholar
  37. 37.
    Ndrepepa G, Schuster T, Hadamitzky M, Byrne RA, Mehilli J, Neumann FJ, Richardt G, Schulz S, Laugwitz KL, Massberg S, Schomig A, Kastrati A (2012) Validation of the Bleeding Academic Research Consortium definition of bleeding in patients with coronary artery disease undergoing percutaneous coronary intervention. Circulation 125:1424–1431CrossRefGoogle Scholar
  38. 38.
    Choi JH, Seo JM, Lee DH, Park K, Kim YD (2015) Clinical utility of new bleeding criteria: a prospective study of evaluation for the Bleeding Academic Research Consortium definition of bleeding in patients undergoing percutaneous coronary intervention. J Cardiol 65:324–329CrossRefGoogle Scholar
  39. 39.
    Lutz J, Menke J, Sollinger D, Schinzel H, Thurmel K (2014) Haemostasis in chronic kidney disease. Nephrol Dial Transpl 29:29–40CrossRefGoogle Scholar
  40. 40.
    Santopinto JJ, Fox KA, Goldberg RJ, Budaj A, Piñero G, Avezum A, Gulba D, Esteban J, Gore JM, Johnson J, Gurfinkel EP, Investigators GRACE (2003) Creatinine clearance and adverse hospital outcomes in patients with acute coronary syndromes: findings from the Global Registry of Acute Coronary Events (GRACE). Heart 89:1003–1008CrossRefGoogle Scholar
  41. 41.
    Best PJ, Lennon R, Ting HH, Bell MR, Rihal CS, Holmes DR, Berger PB (2002) The impact of renal insufficiency on clinical outcomes in patients undergoing percutaneous coronary interventions. J Am Coll Cardiol 39:1113–1119CrossRefGoogle Scholar
  42. 42.
    Mooney JF, Ranasinghe I, Chow CK, Perkovic V, Barzi F, Zoungas S, Holzmann MJ, Welten GM, Biancari F, Wu VC, Tan TC, Cass A, Hillis GS (2013) Preoperative estimates of glomerular filtration rate as predictors of outcome after surgery: a systematic review and meta-analysis. Anesthesiology 118:809–824CrossRefGoogle Scholar

Copyright information

© Springer Japan KK, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Division of CardiologySan Paolo HospitalMilanItaly

Personalised recommendations